HYPERDRIVE

SCIENCE

OUR TECHNOLOGY

01 / FAST

In protein target identification, information on potential targets is normally returned in two weeks given a molecule of interest.

02 / VERSATILE

Multiple libraries from various cell models can be screened concurrently to extract maximal information on the potential binding partners for a molecule of interest.

03 / EASY

A one-stop shop for protein target identification without the need to have any prior information on the potential mode-of-action of a given molecule of interest.

Rapid identification of a protein binin partner for the marine naural produc kahalalide F by using reverse chemical proteomics
Modern methods for the isolation of natural product receptors
Identifying the cellular targets of natural products using T7 phage display
Rapid isolaton of nvel FK506 bindng protens from multiple oganisms using gDNA andcDNA T7 phage display
 
 
 
 

News

 

2019 Hyperdrive Science awarded New South Wales Minimal Viable Product grant

2018 Watch Hyperdrive Science at DEMO NIGHT! Winner of the People's Choice Award for Highest Impact. Live streaming here

https://www.streamgate.co/csiro-on-accelerate4/

CSIRO press release: https://www.csiro.au/en/News/News-releases/2018/ON-demo-night-winners

CSIRO annual awards recognise innovative sci-tech ideas

http://www.manmonthly.com.au/news/csiro-annual-awards-recognise-innovative-sci-tech-ideas/

 

2018 Congratulations to the top 10 for CSIRO ON Accelerate4

 

2018 Macquarie University Congratulates our Hyperdrive team for CSIRO ON Accelerate4 program

 

2017 Hyperdrive makes the top 20 teams for CSIRO ON Acccelerate4 bootcamp

 

CONTACT US

Please fill your contact details below:

Hyperdrive Science
9 Research Park Drive

Macquarie University

NSW 2113

AUSTRALIA

e: peter.karuso@hyperdrivescience.com

 

MEET HYPERDRIVE

OUR STORY

We are a group of scientists and entrepreneurs from Macquarie University that have joined forces to find a new approach to solving problems in the drug discovery and development area.

OUR VISION

We believe that it is possible to improve the current drug discovery process to reduce the cost of health care and increase patient benefits.

OUR TECHNOLOGY

Our technology allows a highly parallel approach to finding potential targets of drug candidates and enables more informed decisions in drug discovery.

OUR TEAM

Dr Fei Liu CBO/CMO

PhD in Chemistry (Yale), postdoc (Harvard) and expert in synthetic chemistry, biosynthesis, chemical proteomics, and network pharmacology

Prof Peter Karuso CEO

PhD in Chemistry (USyd), postdoc (Texas A&M, TUM) and expert in drug discovery, natural products chemistry and phage display. Developed the concept of “reverse chemical proteomics”

Dr Paul Jaschke CTO

PhD in Molecular Biology (UBC), Postdoc (Stanford) and expert in synthetic biology, gene technology, and phage engineering

H

LINKS
ABOUT

Hyperdrive Science
9 Research Park Drive

Macquarie University

NSW 2113

AUSTRALIA

e: peter.karuso@hyperdrivescience.com